MENLO PARK, Calif., Oct. 28, 2014 /PRNewswire/ -- RenovoRx, a leading developer of innovative solutions for the isolation of blood flow and delivery of fluids to selected sites in the vascular system, today announced that the United States Patent and Trademark Office has issued U.S. patent application number 12/958,711 entitled "Devices, Methods and Kits for the Delivery of Therapeutic Material." The issuance of U.S. Patent Number 8,821,476 covers the company's slidable, double balloon catheter for delivering therapies to visceral and peripheral vasculature.

"This patent further strengthens our intellectual property portfolio," said Ramtin Agah, RenovoRx Co-Founder. "We are pleased to receive an issued patent that protects our technology as we prepare to launch the RenovoCath™ RC120 to the market and as we continue product development."

About RenovoRx

RenovoRx (www.renovorx.com) is developing innovative solutions for the isolation of blood flow and delivery of fluids, including diagnostic material and therapeutic agents, to selected sites in the peripheral vascular system. The ability to deliver these materials at high concentration to specific vasculature, safely and without perfusion overlap to other regions, is a central paradigm of the company's technology. RenovoRx is an early stage startup based in Silicon Valley, California.

SOURCE RenovoRx